AlphAIAlphAI — Financial news for AI agents
prnewswire.comOCT 212 min read$PKBK

PARKE BANCORP, INC. ANNOUNCES THIRD QUARTER 2026 EARNINGS

Parke Bancorp (PKBK) reported Q3 2026 net income of $12.2M, up 14.5% YoY, driven by higher net interest income and lower non-interest expenses. Net interest income rose 14.2% to $23M. For the nine months, net income increased 35.9% to $36.2M, with net interest income up 24.8% to $68.2M.

Original reporting
prnewswire.com
Published Oct 21, 2026, 12:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 21, 2026, 12:36 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
PARKE BANCORP, INC. ANNOUNCES THIRD QUARTER 2026 EARNINGS — source image
Source · prnewswire.com
Decision brief

The 30-second read

$PKBKBullishMed
01

Why it matters

The earnings release provides fresh data on net interest income, credit loss provisions, and expense trends, all of which are material for valuation.

02

Market read

First-report earnings for a small-cap regional bank; may trigger short-term price movement.

03

What to watch

Higher provision for credit losses may signal rising loan risk despite income growth.

Relevance 6/10Novelty 7/10Timing: pre-market today

Background

PKBK is a community bank listed on NASDAQ that reported its Q3 2026 results.

Company-level read

Ticker impact

$PKBKBullishMedium confidence
Context

Q3 2026 earnings released with higher net income and interest income versus prior year.

Expected impact

likely upward pressure as investors price in stronger earnings and higher interest income.

Evidence & confidence

The press release presents fresh quarterly numbers that exceed prior-year results, a typical catalyst for short-term price gains in regional banks.

Market effects

Sector

Regional banking sector may see modest uplift as PKBK's earnings suggest favorable interest rate environment.

Regional

U.S. small-cap banking stocks could experience slight gains.

Global

Limited to U.S. regional banks; no broader global impact.

Counterpoint

What could challenge this read

If interest rates reverse lower, PKBK's interest income could decline, tempering upside.

Key entities

  • company
    Parke Bancorp, Inc.

    Issuer of the earnings release.

Read at source← All news

Also covered by

1 outlet

Related articles

OCT 21
$PKBKHigh

PARKE BANCORP, INC. ANNOUNCES THIRD QUARTER 2026 EARNINGS

PARKE BANCORP, INC. (PKBK) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Parke Bancorp, Inc. 601 Delsea Drive, Washington Township, NJ 08080 Contact: Vito S. Pantilione, President and CEO Jonathan D. Hill, Senior Vice President and CFO (856) 256-2500 PARKE BANCORP, INC. ANNOUNCES THIRD QUARTER 2026 EARNINGS Highlights: Net Income: $12.2 m

SEC EDGAR 8-K2 min
JUL 22
$PKBKMed

PARKE BANCORP, INC. ANNOUNCES SECOND QUARTER 2026 EARNINGS

PARKE BANCORP, INC. (PKBK) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex_970396.htm EXHIBIT 99.1 ex_970396.htm Exhibit 99.1 Parke Bancorp, Inc. 601 Delsea Drive, Washington Township, NJ 08080 Contact: Vito S. Pantilione, President and CEO Jonathan D. Hill, Senior Vice President and CFO (856) 256-2500 PARKE BANCORP, INC. ANNOUNCES SECOND Q

SEC EDGAR 8-K4 min
OCT 21
$EFXMedAI 8/10

UBS reiterates Buy on Equifax stock, keeps $220 price target

UBS maintained a Buy rating on Equifax (NYSE:EFX) with a $220 price target, citing strong Q3 earnings and an upbeat outlook. The stock is currently at $174.53, with InvestingPro valuing it at $228.97. Equifax's government business grew to $550M in annual contract value, and its records increased 12% YoY. Analysts have mixed views on its performance, with targets ranging from $175 to $217.

investing.com2 min
OCT 21
$NFLXMed

UBS cuts Netflix stock price target on softer guidance, content concerns

UBS cut Netflix's (NFLX) price target to $100 from $115, citing softer guidance and content concerns. Q3 revenue met expectations, but Q4 guidance was weaker due to one-time expenses. The stock is near its 52-week low, down 45% over the past year. Management expects 2026 revenue at the lower end of prior guidance, with advertising revenue reduced to $2.7B. Multiple analysts adjusted price targets, with ratings ranging from Buy to Overweight.

investing.com2 min
OCT 21
$TMOHighAI 9/10

Thermo Fisher Scientific Q3 Earnings Call Highlights

Thermo Fisher Scientific (TMO) reported Q3 revenue growth across most segments, with Life Sciences up 5%, Analytical Instruments up 6%, and Lab Products up 15%. Specialty Diagnostics saw a 6% revenue decline. Adjusted operating margins improved in all segments. The company introduced AI-enabled products and raised its 2026 revenue and EPS guidance to $47.7B-$48.2B and $25.13-$25.43, respectively. It also completed the divestiture of its microbiology business and repaid $1.1B in senior notes.

finance.yahoo.com2 min